BOLT
Bolt Biotherapeutics, Inc. Common StockstockNASDAQ
At CloseNov 17, 2026 3:59:31 PM EST
5.71USD-1.552%(-0.09)86,612
Pre-marketNov 17, 2026 8:52:30 AM EST
5.57USD-3.966%(-0.23)
After-hoursNov 17, 2026 4:34:30 PM EST
5.54USD-2.977%(-0.17)
Loading…
Loading…
13.46M
Healthcare
Biotechnology
HQ
Redwood City, CA, USA
Previous Close
$5.80
Beta
0.47
52-Week High
$7.78 2026-10-23
52-Week Low
$3.10 2026-09-18
SMA 50
$4.66
SMA 200
$4.50
Avg. Vol 10D
101,888
Avg. Vol 30D
510,978
Avg. Vol 90D
187,753
Relative Vol
0.15
2.36M
1.64M
69.52%
47,382
2.89%
1.00
48%/52%
51.79%
29.92%
6.4300%
100,000
11,432
11,432
11,432
Jun 9, 2025 · 1-for-20 (reverse)
2.5M
-26.2M
-13.55
-24.8M
-1,097.98
-128.77
Nov 12, 2026
Bolt Biotherapeutics GAAP EPS of -$2.25 ·
Seeking Alpha
Nov 10, 2026
Nov 6, 2026
Nov 3, 2026
BOLT Profile
bolt biotherapeutics is a start-up with compelling technology from dr. engleman's lab at stanford university, which demonstrated complete cures in numerous cancer models. the company is backed by strong life sciences investors and is early in its growth curve, seeking bright, highly motivated individuals that will be the company's future leaders to help it further develop and bring to patients novel and curative biotherapies.
BOLT Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 6.30 | 2026-11-10 | -9.37% | 1.206 |
| 1M | 4.00 | 2026-10-16 | +42.75% | -0.045 |
| 3M | 3.20 | 2026-08-17 | +78.44% | 0.520 |
| 6M | 4.36 | 2026-05-18 | +30.96% | 0.334 |
| 1Y | 4.51 | 2025-11-17 | +26.61% | 0.465 |
| 2Y | 11.18 | 2024-11-18 | -48.93% | — |
| 5Y | 180.20 | 2021-11-17 | -96.83% | 0.814 |
BOLT Stock Summary
Bolt Biotherapeutics, Inc. Common Stock (NASDAQ:BOLT) stock price today is $5.71, and today's volume is 78,815. BOLT is down 1.552% today. The 30 day average volume is 510,978. BOLT market cap is $13.46M with 2.36M shares outstanding.